EUDA Health shares surge 10.8% premarket after executing Securities Purchase Agreement for capital raise.

EUDA Health Holdings Limited surged 10.80% in premarket trading following the announcement that its subsidiary, CK Health Plus, expanded into India through a strategic partnership with SafeRock India. The collaboration aims to leverage EUDA’s longevity and wellness expertise in the Indian market, a key growth opportunity. Additionally, CK Health Plus recently secured a direct selling license in Malaysia, further solidifying EUDA’s regional expansion in Asia. These developments, coupled with ongoing advancements in stem cell therapy and immune health products, signaled strong growth potential to investors, driving the premarket rally.